In conversation with Tom Reeves
December 1, 2009 by leonardzehr · Leave a Comment
As CEO of Interface Biologics, Tom Reeves doesn’t dwell on what might have been. For example, a few years ago, as COO of OccuLogix, he came within the blink of an eye of a billion-dollar breakthrough to treat dry age-related macular degeneration. That particular opportunity is no more, but Mr. Reeves likes his chances with [...]
Listen to BioTuesdays 
